SLC6A3 and Parkinson disease: The most studied imaging biomarker is dopamine transporter (DAT) with single photon emission computed tomography ([123I] FP‐CIT SPECT), DAT imaging not only reflects dopamine deficiency but also may be affected by up‐ or downregulation processes in PD.7, 8